CoronaVac from Sinovac triggers quick immune response Reuters Nov 18, 2020 The Sinovac findings came from results in Phase I and Phase II clinical trials in China involving over 700 participants
CanSino gets COVID-19 vaccine patent from China’s IP regulator Reuters Aug 17, 2020 As per reports by state media the patent was issued on August 11
